EVO Visian ICL

Experience Visual Freedom

View Video

EVO Visian ICL, also called an Implantable Collamer® Lens, is a refractive implant to correct common vision issues like myopia (nearsightedness) with or without astigmatism. Unlike some other vision correction options, the EVO Visian ICL is an additive technology that corrects vision without the removal of any corneal tissue. The EVO Visian ICL is meant to reduce or eliminate the need for glasses and contacts and differs from other refractive solutions in that EVO Visian ICL is removable by your doctor.

EVO Visian ICL is made of biocompatible Collamer material that works in harmony with your eye. Your eye doctor will create a small opening in your cornea that will be used to insert and position the EVO Visian ICL.

For most patients, the procedure is virtually painless with numbing drops, and it typically takes less than 20 – 30 minutes. Patients typically experience improved vision right away and a quick recovery time.

Can Provide clear, sharp vision
20-to-30-minute procedure
Quick recovery time
Removable by your doctor
Offers UV protection
Not visible once in place
Can treat nearsightedness with or without astigmatism
Offers an option for patients who may not be candidates for LASIK or other vision correction procedures due to thin corneas (3,4)
Does not cause dry eye syndrome (5)
Excellent night vision (6)

For additional information with potential benefits, risks and complications please visit DiscoverICL.com

There is an out-of-pocket cost for the EVO Visian ICL procedure. This is an elective procedure, not covered by insurance. However, many EVO Visian ICL patients look forward to spending less in the long run with the EVO Visian ICL compared to the continued costs of contacts and glasses.

We encourage you to ask us about financing options that may be available for your EVO Visian ICL procedure. We work with CareCredit and Alphaeon Credit. Additionally, some HSA and FSA plans may allow dollars towards this procedure.

EVO Visian ICL is well-suited for a wide variety of people. Ideal candidates for EVO
Visian ICL are aged 21 to 45 with nearsightedness with or without astigmatism and have
maintained a stable prescription for at least one year.

If you are seeking a solution to decrease or eliminate the cost and frustration of traditional contacts or glasses, EVO Visian ICL may be your answer. Contact us to discuss if EVO Visian ICL is right for you.

The EVO Visian ICL lens is intended to correct/reduce nearsightedness between -3.0 D up to -20.0 D and treat astigmatism from 1.0 D to 4.0 D. If you have nearsightedness within these ranges, EVO Visian ICL surgery may improve your distance vision without eyeglasses or contact lenses.

Because the EVO Visian ICL corrects for distance vision, it does not eliminate the need for reading glasses, you may require them at some point, even if you have never worn them before.

Since implantation of the EVO Visian ICL is a surgical procedure, before considering EVO Visian ICL surgery, you should have a complete eye examination and talk with your eye care professional about EVO Visian ICL surgery, especially the potential benefits, risks, and complications.

You should discuss the time needed for healing after surgery. Complications, although rare, may include need for additional surgical procedures, inflammation, loss of cells from the back surface of the cornea, increase in eye pressure, and cataracts.

You should NOT have EVO Visian ICL surgery if your doctor determines

The shape of your eye is not appropriate.
You do not meet the minimum endothelial cell density for your age at the time of implantation.
You have moderate to severe glaucoma.
Your vision is not stable; or if you are pregnant or nursing.

For additional information with potential benefits, risks and complications please visit DiscoverICL.com

EVO Visian ICL is one option for patients looking for an alternative to LASIK. Other options we offer include PRK and natural lens replacement. Learn more about these procedures now!

Sources:

Sanders D, Vukich J. Comparison of implantable collamer lens (ICL) and laser-assisted in situ keratomileusis (LASIK) for Low Myopia. Cornea. 2006
Igarashi A, Kamiya K, Shimizu K, Komatsu M. Visual Performance after implantable Collamer lens implantation and wavefront-guided laser in situ keratomileusis for high myopia. Am J Opthalmol. 2009
Parkhurst G, Psolka M, Kezirian G. Phakic intraocular lens implantation in United States military warfighters: A retrospective analysis of early clinical outcomes of the Visian ICL. J Refract Surg. 2011;27(7):473-481
Gimbel H, et al. Management of myopic astigmatism with phakic intraocular lens implantation. Journal of Cataract & Refractive Surgery, Volume 28, Issue 5, 883 – 886.
Ganesh S, Brar S, Pawar A. Matched population comparison of visual outcomes and patient satisfaction between 3 modalities for the correction of low to moderate myopic astigmatism. Clin Ophthalmol. 2017 Jul 3;11:1253-1263.
Martinez-Plazs E, Lopez-Miguel A, Lopez-De La Rosa A, et al. Effect of the EVO+ Visian Phakic Implantable Collamer Lens on Visual Performance and Quality of Vision and Life, Am J Ophthalmol 2021;226: 117–125

EVO Visian ICL

Experience Visual Freedom

Font Re-Sizer